St. Jude is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.
Our Mission Statement
Facts & Figures
Visit St. Jude
For updates to our current visitor policy regarding COVID-19, please read.
262 Danny Thomas Place Memphis, TN 38105
Affiliate Clinic Locations
Does your child need treatment?
View Open Clinical Trials
Call: 1-888-226-4343 Fax: 901-595-4011 Email: firstname.lastname@example.org Online: Referral Form Physician / Patient Referral Office
Patient & Family Resources
ExploreTogether, an online resource for anyone facing childhood cancer.
Academic Departments & Divisions
St. Jude Faculty
Comprehensive Cancer Center
Clinical & Research Innovation
Research Resources & Data
News & Publications
St. Jude Graduate School of Biomedical Sciences
Attend a Local Event
To protect your health and support the guidelines for social distancing, we have postponed some fundraising events. Read more.
Volunteer at the Hospital Become a Monthly Donor
Sports and Fitness Fundraisers
Other Ways to Get Involved
Become a Monthly Donor
Why Support Us?
You can mail donations (checks and money orders only) to:
We're currently experiencing some delays in processing donations by mail. Thank you for your support and understanding.
Other Ways to Give
St. Jude Dream Home Giveaway
Shop the Gift Shop
Information for our supporters in response to COVID-19
Discoveries and Achievements
A possible targeted therapy is found for a high-risk form of acute lymphoblastic leukemia, the most common childhood cancer.
National Institutes of Health funding will help physicians and researchers improve hydroxyurea treatment management for sickle cell patients in Memphis.
Research from the Pediatric Cancer Genome Project identifies the mechanism of action for two transcription factors underlying a type of B-precursor acute lymphoblastic leukemia.
Research from the Pediatric Cancer Genome Project identifies genomic landscape that contributes to the diversity of core-binding factor acute myeloid leukemia.
Methotrexate exposure tied to reduced mental flexibility, planning and other executive function skills in long-term survivors of pediatric leukemia.
To improve patient safety, hospital leaders should provide feedback that demonstrates to staff the value of reporting safety events and errors.
From Promise, Winter 2017
Donate Now Subscribe to Promise
Thank you for your feedback!
St. Jude Quality of Life for All team goes above and beyond to improve patients’ psychosocial, emotional, and symptom concerns.
St. Jude staff members help children learn, or re-learn, the art of handwriting.
The STARR program provides academic assistance for children with sickle cell disease and hemophilia.
St. Jude Child Life unites five patients and inspires them to help one another persevere.
Teenagers unite to party with a purpose.
A gift of property supports the hospital’s Genomes for Kids clinical trial.
A chemo combo pioneered at
St. Jude retains a high cure rate for retinoblastoma while preserving usable vision and lowering future cancer risk.
St. Jude scientists use gene editing in quest to help children with sickle cell disease.
There’s ‘clean,’ and then there’s ‘
St. Jude clean.’ Learn some of the tactics
St. Jude uses to keep infection rates low.
Lifestyle expert Sabrina Soto explains how a focus on family makes
St. Jude extra special.
A long-term leukemia survivor runs to help the hospital that saved his life.
For updates on COVID-19, please read.